These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. Joober R; Grizenko N; Sengupta S; Amor LB; Schmitz N; Schwartz G; Karama S; Lageix P; Fathalli F; Torkaman-Zehi A; Ter Stepanian M Neuropsychopharmacology; 2007 Jun; 32(6):1370-6. PubMed ID: 17063150 [TBL] [Abstract][Full Text] [Related]
4. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients. Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517 [TBL] [Abstract][Full Text] [Related]
5. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder. Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198 [TBL] [Abstract][Full Text] [Related]
6. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder. Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy. Thakur GA; Sengupta SM; Grizenko N; Choudhry Z; Joober R PLoS One; 2012; 7(11):e49616. PubMed ID: 23185385 [TBL] [Abstract][Full Text] [Related]
8. Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children. Kim BN; Cummins TD; Kim JW; Bellgrove MA; Hong SB; Song SH; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH Int J Neuropsychopharmacol; 2011 Nov; 14(10):1399-410. PubMed ID: 21733227 [TBL] [Abstract][Full Text] [Related]
9. Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder. Kim BN; Kim JW; Cummins TD; Bellgrove MA; Hawi Z; Hong SB; Yang YH; Kim HJ; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH J Clin Psychopharmacol; 2013 Jun; 33(3):356-62. PubMed ID: 23609393 [TBL] [Abstract][Full Text] [Related]
10. A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Muglia P; Jain U; Kennedy JL Behav Brain Res; 2002 Mar; 130(1-2):91-5. PubMed ID: 11864723 [TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase valine158methionine polymorphism moderates methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder. Salatino-Oliveira A; Genro JP; Zeni C; Polanczyk GV; Chazan R; Guimarães AP; Callegari-Jacques SM; Rohde LA; Hutz MH Biol Psychiatry; 2011 Aug; 70(3):216-21. PubMed ID: 21550019 [TBL] [Abstract][Full Text] [Related]
12. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder. Cheon KA; Cho DY; Koo MS; Song DH; Namkoong K Biol Psychiatry; 2009 Apr; 65(7):564-70. PubMed ID: 19150055 [TBL] [Abstract][Full Text] [Related]
13. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Kent JD; Blader JC; Koplewicz HS; Abikoff H; Foley CA Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692 [TBL] [Abstract][Full Text] [Related]
14. Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children. Cheon KA; Kim BN; Cho SC Neuropsychopharmacology; 2007 Jun; 32(6):1377-83. PubMed ID: 17077808 [TBL] [Abstract][Full Text] [Related]
15. The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD. Thakur GA; Grizenko N; Sengupta SM; Schmitz N; Joober R BMC Psychiatry; 2010 Jun; 10():50. PubMed ID: 20569447 [TBL] [Abstract][Full Text] [Related]
17. Sex-dependent complex association of TPH2 with multiple dimensions of ADHD. Fageera W; Sengupta SM; Fortier MÈ; Grizenko N; Babienco S; Labbe A; Joober R Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110296. PubMed ID: 33677046 [TBL] [Abstract][Full Text] [Related]
18. A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study. Hegvik TA; Jacobsen KK; Fredriksen M; Zayats T; Haavik J J Neural Transm (Vienna); 2016 Aug; 123(8):859-65. PubMed ID: 27091191 [TBL] [Abstract][Full Text] [Related]
19. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335 [TBL] [Abstract][Full Text] [Related]
20. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder. Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]